Published in Circ Cardiovasc Qual Outcomes on September 01, 2012
Intracranial Rescue Stenting for Acute Ischemic Stroke, Predictors of Outcomes | NCT04987710
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57
Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery (2013) 1.58
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51
Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial. Neurology (2015) 1.39
Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Stroke (2015) 0.84
The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future. Stroke (2013) 0.82
Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res (2017) 0.81
Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID? Stroke (2015) 0.80
Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke (2015) 0.78
Simultaneous Bilateral Carotid Stenting for Symptomatic Bilateral High-Grade Carotid Stenosis: A Retrospective Clinical Investigation. Med Sci Monit (2016) 0.75
Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology (2016) 0.75
The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep (2013) 0.75
Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis (2016) 0.75
Blood Pressure Management for Stroke Prevention and in Acute Stroke. J Stroke (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol (2003) 5.77
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
A controlled trial of physician counseling to promote the adoption of physical activity. Prev Med (1996) 4.36
Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol (2008) 4.12
Design of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Int J Stroke (2010) 2.71
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke (2008) 2.68
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol (2005) 2.62
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology (2003) 2.34
Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 1.97
Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol (2004) 1.59
Effectiveness of three models for comprehensive cardiovascular disease risk reduction. Am J Cardiol (2002) 1.32
Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med (1996) 1.27
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial. Am Heart J (2002) 1.21
AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. Circulation (2007) 1.17
Pay for performance in health care: an international overview of initiatives. Med Care Res Rev (2012) 1.08
Rosuvastatin safety: lessons from the FDA review and post-approval surveillance. Expert Opin Drug Saf (2004) 1.04
Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich) (2011) 0.98
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol (2010) 0.97
A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol level. Pharmacotherapy (2004) 0.95
The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol (1997) 0.90
Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology (2006) 0.90
Early aggressive medical management for patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis (2011) 0.83
Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) Trial. Cerebrovasc Dis (2004) 0.81
Containing pandemic influenza at the source. Science (2005) 23.95
Containing pandemic influenza with antiviral agents. Am J Epidemiol (2004) 12.82
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Containing bioterrorist smallpox. Science (2002) 7.62
Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery (2009) 4.49
Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA (2011) 4.46
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol (2010) 4.12
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension (2006) 4.07
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol (2014) 3.88
Histopathological assessment of fatal ipsilateral intraparenchymal hemorrhages after the treatment of supraclinoid aneurysms with the Pipeline Embolization Device. J Neurosurg (2013) 3.65
Risk assessment for ectasia after corneal refractive surgery. Ophthalmology (2007) 3.47
A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis (2002) 3.27
The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol (2010) 3.21
Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol (2005) 3.17
Environmental signatures associated with cholera epidemics. Proc Natl Acad Sci U S A (2008) 3.05
Methodology of the Interventional Management of Stroke III Trial. Int J Stroke (2008) 2.88
Progression is accelerated from prehypertension to hypertension in blacks. Hypertension (2011) 2.82
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
The resident surgeon phacoemulsification learning curve. Arch Ophthalmol (2007) 2.57
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation (2007) 2.50
Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology (2011) 2.49
Epidemic and endemic cholera trends over a 33-year period in Bangladesh. J Infect Dis (2002) 2.39
Mechanical thrombectomy as first-line treatment for venous sinus thrombosis: technical considerations and preliminary results using the AngioJet device. J Neurointerv Surg (2011) 2.36
The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35
ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy. J Neurointerv Surg (2014) 2.34
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value Health (2008) 2.31
Containing a large bioterrorist smallpox attack: a computer simulation approach. Int J Infect Dis (2006) 2.29
Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med (2006) 2.22
Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med (2002) 2.22
Long-term risk of glaucoma after congenital cataract surgery. Am J Ophthalmol (2013) 2.22
Controlling endemic cholera with oral vaccines. PLoS Med (2007) 2.21
Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol (2013) 2.20
Congruency in homonymous hemianopia. Am J Ophthalmol (2007) 2.17
Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med (2005) 2.11
Long-term outcome after angioplasty for symptomatic extracranial carotid stenosis in poor surgical candidates. Stroke (2002) 2.08
One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology (2013) 2.00
A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations' (ARUBA's) trial design challenges notions of external validity. Stroke (2012) 1.96
Prehypertension and cardiovascular morbidity. Ann Fam Med (2005) 1.89
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol (2008) 1.88
Absent relationship between the coil-embolization ratio in small aneurysms treated with a single detachable coil and outcomes. AJNR Am J Neuroradiol (2005) 1.88
Community interventions and the epidemic prevention potential. Vaccine (2002) 1.82
Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke (2007) 1.81
Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol (2009) 1.80
Prehypertension and mortality in a nationally representative cohort. Am J Cardiol (2004) 1.79
Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states. J Neurosurg (2003) 1.77
Management of neuroform stent dislodgement and misplacement. AJNR Am J Neuroradiol (2003) 1.75
Surgical results of the Carotid Occlusion Surgery Study. J Neurosurg (2012) 1.73
Perfusion imaging in acute ischemic stroke: let us improve the science before changing clinical practice. Radiology (2013) 1.70
Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke (2006) 1.68
Endovascular treatment for acute ischemic stroke--still unproven. N Engl J Med (2013) 1.68
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Periodontal disease status in gullah african americans with type 2 diabetes living in South Carolina. J Periodontol (2009) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke (2008) 1.66
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results. Neurology (2014) 1.65
Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis (2005) 1.65
Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg (2011) 1.64
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke (2002) 1.63
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med (2007) 1.62
Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol (2003) 1.61
Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia. Neurology (2014) 1.59
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis (2002) 1.59
Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III. Clin Immunol (2011) 1.59
Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery (2013) 1.58
Comparing indocyanine green videoangiography to the gold standard of intraoperative digital subtraction angiography used in aneurysm surgery. J Neurosurg (2012) 1.58
Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2009) 1.54
Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation (2010) 1.53
Diagnostic yield of computed tomography angiography and magnetic resonance angiography in patients with catheter angiography-negative subarachnoid hemorrhage. J Neurosurg (2012) 1.52
Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis (2014) 1.51